Partner Content A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI November 16, 2016
Partner Content TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications November 16, 2016
Partner Content The Latest Data on Expanded Indications and What it Means for Referring Cardiologists November 16, 2016